Josepovitz C, Levine R, Farruggella T, Kaloyanides G J
Proc Soc Exp Biol Med. 1986 May;182(1):1-5. doi: 10.3181/00379727-182-42300.
We examined the relationship between the nephrotoxicity potential of four aminoglycosides and the capacity of the drugs to induce a renal cortical phospholipidosis. Sprague-Dawley rats were injected subcutaneously with neomycin, gentamicin, tobramycin, or netilmicin, 100 mg/kg per day, for 1 to 4 days, and phospholipid accumulation in the renal cortex and phospholipid excretion in the urine were measured. The rank order of the drug-induced renal cortical phospholipidosis was netilmicin greater than tobramycin greater than gentamicin greater than neomycin. This order is the reverse of the previously established nephrotoxicity potentials of these drugs. Conversely, the rank order according to peak urinary excretion of phospholipids was gentamicin greater than neomycin greater than tobramycin greater than netilmicin. The rank order of the total urinary phospholipid excretion during the 4 days of the study was neomycin greater than or equal to gentamicin greater than tobramycin greater than or equal to netilmicin. Urinary phospholipid excretion may prove to be a sensitive indicator of aminoglycoside nephrotoxicity.
我们研究了四种氨基糖苷类药物的肾毒性潜力与药物诱导肾皮质磷脂沉积症的能力之间的关系。将斯普拉格-道利大鼠皮下注射新霉素、庆大霉素、妥布霉素或奈替米星,剂量为每天100mg/kg,持续1至4天,然后测量肾皮质中的磷脂积累和尿液中的磷脂排泄。药物诱导的肾皮质磷脂沉积症的排序为奈替米星大于妥布霉素大于庆大霉素大于新霉素。这个顺序与这些药物先前确定的肾毒性潜力相反。相反,根据磷脂的尿峰值排泄量排序为庆大霉素大于新霉素大于妥布霉素大于奈替米星。在研究的4天期间,总尿磷脂排泄量的排序为新霉素大于或等于庆大霉素大于妥布霉素大于或等于奈替米星。尿磷脂排泄可能被证明是氨基糖苷类肾毒性的一个敏感指标。